Medtronic to buy fistula creation technology firm Avenu Medical
Avenu's percutaneous fistula creation technology is expected to strengthen Medtronic’s portfolio of peripheral vascular access products for ESRD…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Oct 20
Avenu's percutaneous fistula creation technology is expected to strengthen Medtronic’s portfolio of peripheral vascular access products for ESRD…
30 Sep 20
The acquisition will enable Smith+Nephew to add a complementary shoulder replacement and upper and lower extremities, and a…
22 Sep 20
GRAIL attracted around $2bn investment to boost its technology platform and develop Galleri multi-cancer screening test
22 Sep 20
Farapulse is engaged in developing pulsed field ablation (PFA) system, designed to ablate heart tissue by creating a…
21 Sep 20
The advanced technologies developed by RCSI are said to be effective in the treatment of both hard and…
16 Sep 20
The acquisition is expected to enable Intersect ENT to provide a range of surgical solutions across the sinusitis…
Singapore-based firm eko.ai is one of several start-ups AstraZeneca has partnered with in the ongoing fight to improve…
A walk-through scanner for cancer diagnosis and assistive robotic muscles are among six UK medtech projects receiving government…
03 Sep 20
PCI becomes a part of Medbio and creates a combined medical device manufacturing company, capable of supporting the…
Ablatus plans to put the grant, which was awarded by Innovate UK, towards completing development of its potentially…